Skip to main content
Home
  • about memsorb™
    • frequently asked questions
  • memsorb™ advantage
    • patient safety
    • cost savings
    • environmental stewardship
    • simplicity
  • our technology
  • product support
  • news & articles
  • contact us
Doctor applying a mask

stay up to date on the latest updates and releases from memsorb™

news & articles

IFU - MS-GE

Please reach out to our [email protected] to get the Password

IFU - MS-DR

Please reach out to our [email protected] to get the Password

Health Canada licenses the memsorb device

Halifax-based DMF Medical has received a Class II medical device license from Health Canada to sell its memsorb carbon dioxide filtration device, which has been created to improve safety for patients undergoing general anesthesia.

DMF Medical’s memsorb™ receives Health Canada approval on all major anesthesia platforms in Canada

HALIFAX, Nova Scotia, Canada, May 2021 – DMF Medical Incorporated – a privately held medical device company is pleased to announce that it has received a Class II medical device license from Health Canada to sell its memsorb™ carbon dioxide (CO2) filtration device for general anesthesia in the Canadian market on all major platforms.

Clinical Data Sheet

Low, minimal and metabolic anesthesia using a novel membrane technology instead of chemical absorbents for carbon dioxide removal - clinical data.

CONTACT US
[email protected]

1 Research Drive
Dartmouth, Nova Scotia
Canada  B2Y 4M9

Terms of Use
Privacy Policy
 

© 2020 DMF Medical Incorporated | Web Design by Roddis Communications